When oestrogen symptoms don't add up

You've had the blood test. The results come back and your doctor says your hormone levels look 'normal for your age'. Yet you're sleeping badly, thinking through fog, and experiencing the kind of PMS you thought you'd left behind in your thirties — alongside the occasional hot flush that makes no sense if oestrogen is supposedly fine.

This contradiction is more common than it sounds. Ovarian production gets most of the attention in conversations about hormonal health after 40, but it tells only half the story. The oestrogen circulating in your bloodstream at any given moment is not simply what your ovaries release — it is also shaped by what happens to that oestrogen after the liver has processed it. Whether it leaves the body or re-enters circulation depends, in large part, on your gut.

Most standard hormonal tests do not capture this recycling step at all. The gut microbiome acts as a quiet regulator of oestrogen availability — and understanding how that system works, and what disrupts it after 40, changes the picture considerably.

The estrobolome: your gut's oestrogen recycling system

Think of the liver as a sorting office for spent hormones. Once oestrogen has done its work, the liver stamps it with a chemical tag — glucuronic acid — marking it for disposal and routing it into the intestine. What happens next depends entirely on your gut.

Certain gut bacteria carry genes encoding enzymes that snip off that tag. These enzymes — called β-glucuronidase, or GUS — reverse the liver's labelling work, converting inactivated oestrogen back into its biologically active form. It can then be reabsorbed into circulation rather than excreted: a reuse loop known as enterohepatic recirculation.

The collective name for the gut microbial genes responsible for this is the estrobolome — not the whole microbiome, but a specific functional subset within it. In 2019, Ervin and colleagues analysed 35 distinct GUS enzyme variants from human gut microbiota in vitro and confirmed that each could reactivate oestrogen glucuronides, providing the first direct mechanistic evidence that this is an enzyme-driven process, not a theoretical one.

The estrobolome's reach extends slightly further than recycling alone. The same bacterial populations also convert plant-based oestrogen-like compounds — phytoestrogens found in foods such as soya and flaxseed — into bioactive forms the body can use. This means the gut shapes the overall oestrogenic environment through two routes simultaneously: recycling what the ovaries produce, and unlocking what the diet provides. Both depend on which microbial populations are present and active — a dependency that becomes increasingly significant as ovarian output begins to fall.

How the gut–hormone axis shifts during perimenopause

The relationship between oestrogen and the gut is bidirectional — and that is what makes the perimenopausal years so unsettling for the hormonal system.

Oestrogen does not simply fluctuate in the bloodstream; it actively shapes the gut ecosystem that manages it. Research by Peters (2022) confirms that menopause is associated with measurably lower gut microbial diversity and a compositional shift toward a microbial profile more typically seen in men — a pattern that reflects how significantly female sex hormones have been sustaining gut ecology throughout reproductive life.

Once ovarian output begins to fall — typically from the early forties — that protective influence weakens. The gut loses diversity, and with it, some of the GUS enzyme capacity that drives oestrogen recycling. Less oestrogen is reclaimed from the intestine and returned to circulation. That reduced hormonal signal further diminishes the microbial diversity it once supported. The loop feeds back on itself: lower oestrogen leads to reduced microbial diversity, which reduces GUS activity, which reduces the amount of oestrogen recycled, which lowers circulating oestrogen further still. Wang and colleagues (2025) traced the downstream consequences of this spiral: disrupted lipid metabolism, declining cognitive function, and accelerating bone density loss.

The perimenopausal window — roughly ages 40 to 52 — is when this feedback loop becomes most unstable. Ovarian output is dropping at exactly the point when the gut's compensatory recycling mechanism is already impaired. Two systems that sustain each other begin to falter at the same time, which is why symptoms during this phase can feel disproportionate to the apparent scale of hormonal change. The gut and the hormonal system are not separate problems; they share the same underlying biology.

Two opposite imbalances, one root cause

The counterintuitive point is this: more β-glucuronidase activity is not automatically better. Dysbiosis does not produce a single hormonal outcome — it can push the system in either direction, depending on which bacterial populations happen to dominate at any given time.

Where dysbiosis involves an overgrowth of heavy GUS-producing bacteria, oestrogen is recycled in excess. Research suggests this pattern may contribute to a state of relative oestrogen dominance — characterised by heavy or irregular periods, breast tenderness, and pronounced PMS. Conversely, when dysbiosis suppresses GUS activity, oestrogen is cleared too quickly and circulating levels fall further. This deficiency state is more closely associated with hot flushes, persistent fatigue, brain fog, and, over time, increased risk of bone density loss.

For women in perimenopause, both states may occur at different points as gut composition fluctuates. This oscillation may partly explain why symptoms during this phase can feel inconsistent — the underlying microbial environment is genuinely shifting.

Phytoestrogen conversion adds a further layer of individual variation. Gut bacteria — particularly certain Lactobacillus strains — help convert plant-based oestrogen-like compounds into bioactive forms, offering some natural buffering. But this capacity varies considerably between individuals, reflecting which microbial species are actually present and active.

Practical levers for supporting the estrobolome

Translating this biology into daily practice starts with the dinner plate. Diverse plant foods — legumes, wholegrains, vegetables, seeds — provide the dietary fibre that physically binds free oestrogens in the gut, slowing their reabsorption and reducing the load on β-GUS pathways. Research associates higher fibre intake with healthier oestrogen clearance patterns: a passive but consistent buffering effect that requires no supplements, only variety.

Cruciferous vegetables such as broccoli, kale, and Brussels sprouts offer a more targeted contribution. They contain compounds including calcium-D-glucarate and dietary polyphenols that may act as natural inhibitors of bacterial β-glucuronidase — gently modulating excessive recycling rather than blocking it wholesale. The evidence here is promising; it should be read as support rather than intervention.

Probiotic supplementation — specifically strains from the Lactobacillus and Bifidobacterium families — represents an active area of research. Some studies suggest these bacteria can shift GUS enzyme activity in either direction depending on the host's existing microbiome state, though direct randomised trial evidence in perimenopausal women remains limited. Peters (2022) calls explicitly for larger, replicable studies before firmer conclusions can be drawn. This is research-stage territory, not a treatment.

Cortisol should not be overlooked. Chronic stress elevates cortisol in ways that alter gut motility and destabilise microbial composition, compounding the very hormonal instability that perimenopause already creates. Consistent sleep, regular movement, and deliberate recovery time are not peripheral considerations for gut-hormone health — they are part of the same system. For those who want the approach to be data-led, periodic hormonal and metabolic blood testing through a qualified clinician can reveal how these patterns are shifting over time.

Anyone with specific hormonal health concerns should speak with a healthcare professional before making significant dietary or supplement changes.

Seeing gut and hormones as one system

The gut–hormone axis described in this article sits precisely at the intersection of two pillars that Professor Paul Lee's Regeneration by Design treats as inseparable: Biology — the body understood as a living ecosystem — and Chemistry, the hormonal and metabolic environment that ecosystem sustains. The book's central argument is that these are not parallel tracks but interlocking feedback loops, and the estrobolome is one of the clearest anatomical demonstrations of that point.

The practical implication of viewing it this way is that the direction of action opens up. GUS enzyme activity is not a fixed trait — it shifts with what you eat, how well you sleep, and how much cortisol you carry into the week. The perimenopausal transition may narrow the margin, but it does not close it. Treating gut diversity as part of ongoing health architecture, rather than a crisis to address once symptoms tip over, is the mindset the evidence actually supports: varied fibre, targeted plant compounds, and managed stress influence which microbial populations thrive and, downstream, how much oestrogen completes the enterohepatic loop rather than being discarded.

This article is educational wellness information and is not a substitute for professional medical advice. Anyone with specific hormonal health concerns should consult a qualified healthcare professional.

1. [1] Estrobolome. https://en.wikipedia.org/?curid=81621323 https://en.wikipedia.org/?curid=81621323